2014
DOI: 10.3103/s0891416814030033
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphism of the biotransformation gene cytochrome-450 2C9 in patients with tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…According to the literature data, the main toxicity of isoniazid administration was connected to the formation of toxic metabolites such as acetylhydrazine and hydrazine. [16][17][18] Therefore, the rapid decrease in the isoniazid serum level (in individuals with rapid acetylator phenotype) with the predominant formation of the low-toxicity acetylisoniazid led to a lower risk of isoniazid toxicity. In contrast, the slow decrease in the serum isoniazid concentration (in individuals with slow acetylators) could cause an intensive formation of hydrazine, which explained the higher risk of isoniazid toxicity in this category of individuals.…”
Section: Discussionmentioning
confidence: 99%
“…According to the literature data, the main toxicity of isoniazid administration was connected to the formation of toxic metabolites such as acetylhydrazine and hydrazine. [16][17][18] Therefore, the rapid decrease in the isoniazid serum level (in individuals with rapid acetylator phenotype) with the predominant formation of the low-toxicity acetylisoniazid led to a lower risk of isoniazid toxicity. In contrast, the slow decrease in the serum isoniazid concentration (in individuals with slow acetylators) could cause an intensive formation of hydrazine, which explained the higher risk of isoniazid toxicity in this category of individuals.…”
Section: Discussionmentioning
confidence: 99%